HUMAN C1-ESTERASE INHIBITOR

HUMAN C1-ESTERASE INHIBITOR was reported 14668 times

HUMAN C1-ESTERASE INHIBITOR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEREDITARY ANGIOEDEMA 6235 0.5804
1 HEPATIC ENZYME 73 0.4899
2 C1 ESTERASE INHIBITOR DECREASED 6 0.4000
3 HYPOCHOLESTEROLAEMIA 98 0.2776
4 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, MIXED TYPE 6 0.2609
5 FACET JOINT SYNDROME 704 0.2160
6 PERIPHERAL VENOUS DISEASE 640 0.1566
7 LARYNGEAL DYSKINESIA 20 0.1550
8 OVERLAP SYNDROME 105 0.1500
9 ONYCHOMADESIS 551 0.1312
10 VASCULAR ACCESS SITE COMPLICATION 31 0.1230
11 RHEUMATIC FEVER 547 0.1226
12 BREAST CANCER STAGE III 790 0.1219
13 BLEPHAROSPASM 747 0.1185
14 LARYNGEAL STENOSIS 67 0.1159
15 SWOLLEN JOINT COUNT 26 0.1040
16 DUODENAL ULCER PERFORATION 756 0.1016
17 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 721 0.1005
18 DISEASE PRODROMAL STAGE 5 0.0980
19 ONYCHOMYCOSIS 426 0.0970
20 VOCAL CORD DYSFUNCTION 47 0.0953
21 LUPUS VULGARIS 117 0.0929
22 INFUSION SITE REACTION 244 0.0816
23 MUSCLE INJURY 662 0.0798
24 FOLLICULITIS 804 0.0766
25 HELICOBACTER INFECTION 755 0.0734
26 NAIL DISORDER 641 0.0732
27 FINGER DEFORMITY 351 0.0724
28 LIP DRY 628 0.0691
29 C-REACTIVE PROTEIN 63 0.0680
30 HYPERCHOLESTEROLAEMIA 643 0.0665
31 BURSITIS 806 0.0664
32 PEMPHIGUS 827 0.0661
33 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 37 0.0660
34 DISLOCATION OF VERTEBRA 146 0.0640
35 LIVE BIRTH 535 0.0639
36 C-REACTIVE PROTEIN ABNORMAL 405 0.0631
37 WOUND INFECTION 671 0.0612
38 HAND DEFORMITY 745 0.0567
39 X-RAY ABNORMAL 101 0.0564
40 DEEP VEIN THROMBOSIS POSTOPERATIVE 113 0.0564
41 BACK INJURY 588 0.0540
42 GRIP STRENGTH DECREASED 474 0.0538
43 RETINITIS 93 0.0538
44 PRODUCT LABEL CONFUSION 299 0.0513
45 PERICARDITIS 844 0.0502
46 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 5 0.0476
47 JOINT RANGE OF MOTION DECREASED 635 0.0473
48 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 97 0.0468
49 SWOLLEN JOINT COUNT INCREASED 145 0.0454
50 SYNOVITIS 809 0.0448
51 COELIAC DISEASE 393 0.0400
52 OBESITY 621 0.0389
53 CENTRAL VENOUS CATHETER REMOVAL 18 0.0384
54 PORPHYRIA ACUTE 52 0.0362
55 GLOSSODYNIA 797 0.0356
56 PRODUCT PREPARATION ISSUE 231 0.0352
57 GRIP STRENGTH 8 0.0349
58 BONE EROSION 115 0.0325
59 TASTE DISORDER 648 0.0319
60 IRRITABLE BOWEL SYNDROME 680 0.0317
61 CONGENITAL ANOMALY 240 0.0310
62 PRODUCT RECONSTITUTION QUALITY ISSUE 26 0.0291
63 FIBROMYALGIA 697 0.0286
64 PRESCRIBED OVERDOSE 529 0.0273
65 WOUND 764 0.0273
66 BLOOD IMMUNOGLOBULIN E INCREASED 63 0.0260
67 ALLERGY TO VACCINE 8 0.0259
68 RESPIRATORY TRACT OEDEMA 19 0.0256
69 EPILEPSY 772 0.0252
70 TYPE 2 DIABETES MELLITUS 838 0.0249
71 BLOOD IMMUNOGLOBULIN E DECREASED 4 0.0248
72 ADVERSE REACTION 329 0.0248
73 LIVER INJURY 605 0.0246
74 SYSTEMIC LUPUS ERYTHEMATOSUS 873 0.0246
75 INSURANCE ISSUE 375 0.0245
76 TRACHEOSTOMY MALFUNCTION 5 0.0242
77 NORMAL NEWBORN 131 0.0241
78 ENTEROBACTER BACTERAEMIA 7 0.0231
79 RHEUMATOID FACTOR POSITIVE 130 0.0225
80 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 15 0.0225
81 LOCALISED OEDEMA 103 0.0222
82 LIVER FUNCTION TEST INCREASED 472 0.0220
83 PSORIATIC ARTHROPATHY 875 0.0215
84 IMPAIRED HEALING 707 0.0215
85 CONTRAINDICATED PRODUCT ADMINISTERED 636 0.0210
86 C-REACTIVE PROTEIN INCREASED 762 0.0209
87 POOR VENOUS ACCESS 216 0.0209
88 COMPLEMENT FACTOR C4 DECREASED 4 0.0208
89 TRACHEAL HAEMORRHAGE 7 0.0199
90 LARYNGEAL OEDEMA 122 0.0198
91 THERAPY REGIMEN CHANGED 8 0.0197
92 ADMINISTRATION SITE PAIN 22 0.0191
93 GAIT INABILITY 608 0.0182
94 PRODUCT SUPPLY ISSUE 128 0.0179
95 CHRONIC SINUSITIS 67 0.0178
96 NIGHT SWEATS 572 0.0177
97 INFUSION SITE BRUISING 38 0.0176
98 ADMINISTRATION SITE ERYTHEMA 5 0.0175
99 NAIL OPERATION 7 0.0169
100 LARYNGEAL DISORDER 12 0.0166
101 BREAST CANCER STAGE II 137 0.0165
102 EXOSTOSIS 150 0.0164
103 MALABSORPTION FROM INJECTION SITE 5 0.0161
104 MATERNAL EXPOSURE DURING BREAST FEEDING 64 0.0158
105 BLOOD CHOLESTEROL INCREASED 727 0.0156
106 PHARYNGEAL OEDEMA 239 0.0155
107 PRODUCT DISTRIBUTION ISSUE 144 0.0155
108 AUTOIMMUNE DISORDER 150 0.0154
109 OSTEOARTHRITIS 641 0.0151
110 SERONEGATIVE ARTHRITIS 17 0.0148
111 PHARYNGEAL SWELLING 145 0.0148
112 CATHETER SITE THROMBOSIS 4 0.0146
113 INFLAMMATION 752 0.0146
114 LOWER RESPIRATORY TRACT INFECTION 658 0.0145
115 DRUG-INDUCED LIVER INJURY 453 0.0144
116 INFUSION RELATED REACTION 956 0.0144
117 ARTHROPATHY 796 0.0143
118 HEPATITIS 357 0.0139
119 RED BLOOD CELL SEDIMENTATION RATE INCREASED 153 0.0138
120 AXILLARY VEIN THROMBOSIS 5 0.0135
121 BLISTER 744 0.0132
122 LUNG DISORDER 648 0.0132
123 THERAPY CHANGE 130 0.0132
124 ALLERGY TO PLANTS 6 0.0131
125 ADMINISTRATION SITE REACTION 5 0.0130
126 CENTRAL VENOUS CATHETERISATION 39 0.0129
127 MATERNAL EXPOSURE DURING PREGNANCY 1131 0.0127
128 ULCER HAEMORRHAGE 84 0.0124
129 DEATH OF RELATIVE 5 0.0123
130 WHEEZING 725 0.0122
131 THERAPEUTIC PRODUCT EFFECT DECREASED 532 0.0119
132 DRUG TOLERANCE 60 0.0118
133 STOMATITIS 706 0.0116
134 ADMINISTRATION SITE BRUISE 4 0.0115
135 STRESS AT WORK 13 0.0115
136 INFUSION SITE SCAR 5 0.0113
137 MUSCULOSKELETAL PAIN 591 0.0113
138 ABDOMINAL SYMPTOM 9 0.0112
139 NEUROGENIC SHOCK 6 0.0111
140 PRODUCT CLOSURE ISSUE 6 0.0108
141 HEPATIC ENZYME INCREASED 735 0.0108
142 SWELLING 1005 0.0107
143 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 181 0.0105
144 INTENTIONAL PRODUCT USE ISSUE 915 0.0104
145 VEIN COLLAPSE 8 0.0104
146 BODY HEIGHT INCREASED 5 0.0102
147 VEIN RUPTURE 17 0.0101
148 ILL-DEFINED DISORDER 602 0.0099
149 PUSTULAR PSORIASIS 34 0.0099
150 LUPUS-LIKE SYNDROME 89 0.0098
151 GASTROOESOPHAGEAL REFLUX DISEASE 786 0.0098
152 MIXED CONNECTIVE TISSUE DISEASE 4 0.0095
153 INFUSION SITE VESICLES 5 0.0095
154 TRACHEITIS 7 0.0092
155 EXPOSURE DURING PREGNANCY 571 0.0092
156 MITE ALLERGY 6 0.0092
157 NO ADVERSE EVENT 1659 0.0091
158 DELIVERY 6 0.0091
159 NECK PAIN 506 0.0090
160 BREAST FEEDING 7 0.0090
161 WALKING AID USER 58 0.0088
162 ALLERGY TO ARTHROPOD STING 4 0.0088
163 GENITAL SWELLING 6 0.0087
164 INFUSION SITE DISCOMFORT 9 0.0087
165 DENTAL CARE 16 0.0086
166 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 56 0.0086
167 DRY MOUTH 699 0.0086
168 SLEEP DISORDER 608 0.0086
169 DRUG TOLERANCE DECREASED 24 0.0085
170 MOBILITY DECREASED 614 0.0085
171 HEPATITIS C VIRUS TEST POSITIVE 5 0.0085
172 FACIAL DISCOMFORT 6 0.0085
173 LOWER LIMB FRACTURE 162 0.0084
174 JUGULAR VEIN THROMBOSIS 15 0.0084
175 DEVICE RELATED INFECTION 127 0.0082
176 DEVICE RELATED THROMBOSIS 8 0.0081
177 JOINT DESTRUCTION 12 0.0077
178 TRACHEOSTOMY 11 0.0077
179 INFUSION SITE PAIN 99 0.0077
180 INFUSION SITE HAEMORRHAGE 25 0.0076
181 RHEUMATOID ARTHRITIS 853 0.0075
182 DRUG INTOLERANCE 716 0.0074
183 INFUSION SITE MASS 8 0.0074
184 WEIGHT FLUCTUATION 77 0.0074
185 INJURY 513 0.0073
186 PRESCRIBED UNDERDOSE 142 0.0071
187 GENERAL PHYSICAL HEALTH DETERIORATION 823 0.0071
188 OBSTRUCTIVE AIRWAYS DISORDER 79 0.0071
189 INJECTION SITE REACTION 488 0.0071
190 SUBCLAVIAN VEIN THROMBOSIS 8 0.0070
191 MIGRAINE 663 0.0069
192 MATERNAL EXPOSURE TIMING UNSPECIFIED 26 0.0069
193 PULMONARY FIBROSIS 132 0.0069
194 WISDOM TEETH REMOVAL 9 0.0068
195 BLOOD OESTROGEN INCREASED 4 0.0068
196 SCIATICA 107 0.0067
197 PRODUCT DOSE OMISSION IN ERROR 188 0.0066
198 GASTROINTESTINAL DISORDER 592 0.0066
199 INCORRECT DRUG ADMINISTRATION RATE 28 0.0066
200 ALLERGY TO ANIMAL 7 0.0066
201 DEVICE RELATED SEPSIS 13 0.0065
202 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 8 0.0064
203 VENOUS INJURY 6 0.0064
204 SUSPECTED OFF LABEL USE 29 0.0064
205 MAST CELL ACTIVATION SYNDROME 9 0.0064
206 RASH VESICULAR 31 0.0064
207 VASCULAR DEVICE INFECTION 29 0.0064
208 MONOCLONAL GAMMOPATHY 4 0.0064
209 ABDOMINAL DISTENSION 666 0.0064
210 TREATMENT DELAYED 11 0.0064
211 INFUSION SITE PRURITUS 20 0.0063
212 SUPERINFECTION BACTERIAL 5 0.0063
213 JOINT SWELLING 761 0.0063
214 EYE INJURY 19 0.0062
215 TREATMENT FAILURE 514 0.0062
216 PANCREATITIS RELAPSING 5 0.0061
217 DENTAL OPERATION 15 0.0061
218 EAR PAIN 117 0.0060
219 VEIN DISORDER 30 0.0060
220 HEPATIC CIRRHOSIS 112 0.0060
221 EMERGENCY CARE 18 0.0059
222 HYPOAESTHESIA 860 0.0057
223 PREGNANCY 115 0.0057
224 HAEMATOLOGICAL INFECTION 14 0.0057
225 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 407 0.0057
226 GASTROINTESTINAL OEDEMA 10 0.0057
227 GASTRIC OPERATION 5 0.0054
228 PERIPHERAL SWELLING 832 0.0054
229 BLISTER RUPTURE 4 0.0054
230 DYSPEPSIA 525 0.0053
231 LIMB CRUSHING INJURY 4 0.0053
232 CATHETER SITE INFECTION 20 0.0053
233 CONFUSIONAL STATE 852 0.0053
234 COMPLICATION OF PREGNANCY 4 0.0053
235 ANIMAL BITE 14 0.0052
236 INFUSION SITE NODULE 5 0.0052
237 WEIGHT INCREASED 1152 0.0051
238 ORAL SURGERY 12 0.0051
239 URTICARIA 845 0.0050
240 PHARYNGEAL PARAESTHESIA 8 0.0050
241 MUSCULOSKELETAL STIFFNESS 440 0.0050
242 CATHETER SITE PAIN 13 0.0050
243 ENDOTRACHEAL INTUBATION 14 0.0050
244 MEMORY IMPAIRMENT 682 0.0050
245 INFUSION SITE WARMTH 6 0.0049
246 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 345 0.0048
247 PRODUCT USE ISSUE 904 0.0048
248 ABDOMINAL DISCOMFORT 805 0.0048
249 COVID-19 IMMUNISATION 4 0.0048
250 INCISION SITE COMPLICATION 4 0.0048
251 INFUSION SITE SWELLING 30 0.0048
252 MUSCULAR WEAKNESS 536 0.0047
253 PRODUCT QUALITY ISSUE 636 0.0047
254 OVARIAN CYST RUPTURED 6 0.0047
255 SPONDYLITIS 17 0.0047
256 INFUSION SITE IRRITATION 6 0.0047
257 CRANIOFACIAL FRACTURE 4 0.0047
258 PATIENT DISSATISFACTION WITH TREATMENT 9 0.0047
259 DISCOMFORT 282 0.0046
260 LIP INJURY 6 0.0046
261 PNEUMONIA PSEUDOMONAL 7 0.0046
262 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 219 0.0046
263 INFUSION SITE DISCOLOURATION 4 0.0045
264 PARAESTHESIA 713 0.0045
265 PHARYNGEAL DISORDER 13 0.0045
266 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 76 0.0045
267 NASOPHARYNGITIS 820 0.0044
268 METABOLIC SURGERY 5 0.0044
269 VULVOVAGINAL SWELLING 8 0.0044
270 INFUSION SITE RASH 6 0.0044
271 UNDERDOSE 317 0.0043
272 SINUS DISORDER 86 0.0043
273 BIOPSY 4 0.0043
274 LOCAL SWELLING 75 0.0043
275 CATHETER SITE SWELLING 4 0.0043
276 ARTHROPOD STING 7 0.0042
277 ANGIOEDEMA 186 0.0042
278 INFUSION SITE ERYTHEMA 35 0.0041
279 FOOD ALLERGY 32 0.0041
280 MYOSITIS 37 0.0041
281 ANIMAL SCRATCH 4 0.0041
282 MUSCLE SPASMS 746 0.0041
283 ABDOMINAL PAIN UPPER 830 0.0040
284 RESPIRATORY DISORDER 120 0.0040
285 ROAD TRAFFIC ACCIDENT 167 0.0040
286 SUSPECTED COVID-19 13 0.0039
287 SWOLLEN TONGUE 123 0.0039
288 HYPERTENSION 834 0.0039
289 RUBBER SENSITIVITY 6 0.0039
290 HORMONE LEVEL ABNORMAL 19 0.0039
291 INCORRECT PRODUCT ADMINISTRATION DURATION 84 0.0039
292 INJECTION SITE SCAR 11 0.0039
293 HEART TRANSPLANT REJECTION 4 0.0039
294 EOSINOPHILIA 67 0.0038
295 ALOPECIA 743 0.0038
296 CATHETER PLACEMENT 7 0.0038
297 JOINT STIFFNESS 99 0.0038
298 MIDDLE INSOMNIA 70 0.0037
299 STRIDOR 11 0.0037
300 MECHANICAL VENTILATION 7 0.0037
301 PRODUCT USE IN UNAPPROVED INDICATION 905 0.0036
302 JOINT DISLOCATION 38 0.0036
303 TREATMENT NONCOMPLIANCE 195 0.0036
304 PRODUCT USE COMPLAINT 56 0.0036
305 HIP ARTHROPLASTY 54 0.0035
306 INTENSIVE CARE 5 0.0035
307 GASTROINTESTINAL BACTERIAL INFECTION 4 0.0035
308 FREQUENT BOWEL MOVEMENTS 94 0.0035
309 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 8 0.0035
310 DEPRESSION 769 0.0034
311 DEVICE ISSUE 300 0.0033
312 PRODUCT AVAILABILITY ISSUE 75 0.0033
313 CATHETER SITE ERYTHEMA 7 0.0033
314 EXPOSURE VIA BREAST MILK 13 0.0033
315 GENERAL SYMPTOM 24 0.0032
316 FUNGAEMIA 5 0.0032
317 CONDITION AGGRAVATED 958 0.0031
318 HYPERSENSITIVITY 580 0.0031
319 INFECTIOUS MONONUCLEOSIS 7 0.0031
320 THERAPEUTIC PRODUCT EFFECT DELAYED 14 0.0031
321 MULTIPLE ALLERGIES 24 0.0031
322 MEDICAL PROCEDURE 5 0.0030
323 THERAPY INTERRUPTED 213 0.0030
324 FEAR OF INJECTION 21 0.0029
325 SEASONAL ALLERGY 41 0.0029
326 EAR INFECTION 77 0.0029
327 PHARYNGITIS STREPTOCOCCAL 31 0.0029
328 FOREIGN BODY IN THROAT 9 0.0029
329 CONTUSION 275 0.0029
330 OEDEMA 153 0.0028
331 FEAR OF DISEASE 5 0.0028
332 FOOT DEFORMITY 31 0.0028
333 DELIRIUM 97 0.0028
334 SPINAL FUSION SURGERY 11 0.0027
335 ARTHROPOD BITE 20 0.0027
336 SINUSITIS 276 0.0027
337 OROPHARYNGEAL DISCOMFORT 24 0.0027
338 TOOTH EXTRACTION 33 0.0026
339 SWELLING FACE 172 0.0026
340 DISABILITY 52 0.0026
341 KNEE ARTHROPLASTY 55 0.0026
342 AORTIC STENOSIS 9 0.0026
343 CONCUSSION 20 0.0026
344 PRODUCT DOSE OMISSION ISSUE 755 0.0026
345 PRODUCT CONTAINER ISSUE 22 0.0026
346 ADVERSE EVENT 236 0.0026
347 ASPIRATION 28 0.0026
348 LIGAMENT SPRAIN 25 0.0025
349 SKIN LESION 69 0.0025
350 THERAPEUTIC RESPONSE DELAYED 7 0.0025
351 TONSILLITIS 13 0.0025
352 FOETAL EXPOSURE DURING PREGNANCY 202 0.0025
353 ADVERSE DRUG REACTION 222 0.0025
354 OSTEOPOROSIS 101 0.0025
355 INJECTION SITE INFECTION 8 0.0024
356 INJECTION RELATED REACTION 4 0.0024
357 ASTHENIA 908 0.0024
358 WEIGHT DECREASED 671 0.0024
359 BACK DISORDER 39 0.0024
360 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 131 0.0024
361 POST-TRAUMATIC STRESS DISORDER 16 0.0024
362 PRODUCT SOLUBILITY ABNORMAL 12 0.0024
363 SLEEP DEFICIT 5 0.0024
364 PRODUCT DOSE OMISSION 154 0.0024
365 PNEUMONIA 759 0.0023
366 LIQUID PRODUCT PHYSICAL ISSUE 17 0.0023
367 THERAPY CESSATION 117 0.0023
368 POLYARTHRITIS 12 0.0023
369 OFF LABEL USE 1992 0.0023
370 GASTROENTERITIS VIRAL 41 0.0023
371 COLONOSCOPY 5 0.0023
372 ACCIDENT AT WORK 5 0.0023
373 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 6 0.0023
374 MOUTH SWELLING 13 0.0023
375 INFUSION SITE EXTRAVASATION 14 0.0022
376 THERAPY NON-RESPONDER 101 0.0022
377 FEAR OF DEATH 5 0.0022
378 UNEVALUABLE EVENT 167 0.0022
379 PERIARTHRITIS 5 0.0022
380 HYSTERECTOMY 19 0.0022
381 ASTHMA 247 0.0022
382 TOOTH ABSCESS 22 0.0022
383 STREPTOCOCCAL INFECTION 12 0.0022
384 NECK SURGERY 5 0.0021
385 ARTHRALGIA 884 0.0021
386 LIVER DISORDER 94 0.0021
387 THERMAL BURN 15 0.0021
388 FRUSTRATION TOLERANCE DECREASED 17 0.0021
389 DYSPHONIA 123 0.0021
390 TONGUE OEDEMA 8 0.0021
391 INJECTION SITE DISCOMFORT 22 0.0021
392 PROCEDURAL COMPLICATION 16 0.0021
393 ABDOMINAL PAIN 479 0.0021
394 RASH 889 0.0020
395 INABILITY TO AFFORD MEDICATION 20 0.0020
396 GASTROINTESTINAL INFECTION 18 0.0020
397 GASTROINTESTINAL TUBE INSERTION 5 0.0020
398 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 361 0.0020
399 LIMB INJURY 54 0.0020
400 VIRAL INFECTION 66 0.0020
401 EAR HAEMORRHAGE 4 0.0020
402 FIBRIN D DIMER INCREASED 7 0.0020
403 INJECTION SITE IRRITATION 25 0.0020
404 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 12 0.0019
405 PHYSICAL DECONDITIONING 5 0.0019
406 MENOPAUSE 5 0.0019
407 HOSPITALISATION 298 0.0019
408 KIDNEY INFECTION 38 0.0019
409 CHEST INJURY 4 0.0019
410 COMPLICATION ASSOCIATED WITH DEVICE 28 0.0019
411 COMPARTMENT SYNDROME 5 0.0019
412 ENDOMETRIOSIS 9 0.0019
413 DIZZINESS 941 0.0019
414 PROTEIN TOTAL INCREASED 5 0.0019
415 VOMITING 881 0.0019
416 INSOMNIA 498 0.0019
417 FOOD POISONING 10 0.0019
418 UPPER RESPIRATORY TRACT INFECTION 86 0.0019
419 MALAISE 816 0.0019
420 ABDOMINAL RIGIDITY 5 0.0018
421 PANCREATIC DISORDER 9 0.0018
422 PAIN IN EXTREMITY 538 0.0018
423 NONSPECIFIC REACTION 10 0.0018
424 CHOLECYSTITIS INFECTIVE 5 0.0018
425 LYME DISEASE 6 0.0018
426 ANAPHYLACTIC REACTION 99 0.0018
427 OXYGEN SATURATION ABNORMAL 5 0.0018
428 FEELING HOT 108 0.0018
429 MEDICAL DEVICE COMPLICATION 13 0.0018
430 PAIN 1079 0.0018
431 DERMATITIS CONTACT 20 0.0018
432 LIP SWELLING 58 0.0017
433 INFECTION 252 0.0017
434 VASCULAR GRAFT 5 0.0017
435 VOMITING PROJECTILE 5 0.0017
436 BILIARY COLIC 5 0.0017
437 THROMBOPHLEBITIS 6 0.0017
438 DISCOURAGEMENT 4 0.0017
439 ILLNESS 175 0.0017
440 INGROWING NAIL 4 0.0017
441 AMNESIA 110 0.0017
442 FALL 556 0.0017
443 LIMB OPERATION 8 0.0017
444 PANCREATITIS 88 0.0017
445 HIP SURGERY 9 0.0017
446 APHONIA 23 0.0016
447 WHITE BLOOD CELL COUNT INCREASED 63 0.0016
448 HEPATIC PAIN 7 0.0016
449 PRODUCT DISPENSING ISSUE 7 0.0016
450 CHOKING SENSATION 9 0.0016
451 DERMAL CYST 4 0.0016
452 PHARYNGITIS 20 0.0016
453 MATERNAL EXPOSURE BEFORE PREGNANCY 11 0.0016
454 ANEURYSM 8 0.0016
455 PRODUCT LEAKAGE 9 0.0016
456 ENDODONTIC PROCEDURE 4 0.0016
457 MENINGITIS ASEPTIC 7 0.0016
458 DECREASED APPETITE 360 0.0015
459 LIPOMA 4 0.0015
460 INJECTION SITE BRUISING 123 0.0015
461 HERNIA REPAIR 4 0.0015
462 BRAIN FOG 24 0.0015
463 THROMBOSIS IN DEVICE 5 0.0015
464 BRAIN OEDEMA 19 0.0015
465 NASAL DISORDER 4 0.0015
466 HEADACHE 941 0.0015
467 ABDOMINAL MASS 4 0.0015
468 LARYNGOSPASM 4 0.0015
469 INJECTION SITE VESICLES 9 0.0015
470 TOOTH DISORDER 33 0.0015
471 SKIN LACERATION 16 0.0015
472 CHEST PAIN 272 0.0015
473 INFLUENZA 163 0.0015
474 HEAD INJURY 46 0.0015
475 SOCIAL PROBLEM 6 0.0014
476 TOOTH INFECTION 19 0.0014
477 HYPERTRANSAMINASAEMIA 10 0.0014
478 BOWEL MOVEMENT IRREGULARITY 11 0.0014
479 THROMBOSIS 114 0.0014
480 PRODUCT CONTAMINATION 5 0.0014
481 ABORTION SPONTANEOUS 56 0.0014
482 MONOPLEGIA 6 0.0014
483 DYSPNOEA 781 0.0014
484 FOOT FRACTURE 26 0.0014
485 CHEST DISCOMFORT 140 0.0014
486 PSYCHIATRIC SYMPTOM 10 0.0014
487 BRONCHITIS 100 0.0013
488 NEEDLE ISSUE 39 0.0013
489 BLOOD CULTURE POSITIVE 4 0.0013
490 SENSITIVITY TO WEATHER CHANGE 7 0.0013
491 DRUG EFFECT DELAYED 6 0.0013
492 CRANIOCEREBRAL INJURY 4 0.0013
493 COVID-19 231 0.0013
494 ABDOMINAL HERNIA 6 0.0013
495 INJECTION SITE URTICARIA 32 0.0013
496 INJECTION SITE DISCHARGE 7 0.0013
497 OESOPHAGEAL DISORDER 5 0.0013
498 CAESAREAN SECTION 15 0.0013
499 DRUG INEFFECTIVE 1695 0.0013
500 APPENDICITIS 12 0.0013
501 COVID-19 PNEUMONIA 15 0.0013
502 SKIN ABRASION 6 0.0013
503 VIRAL UPPER RESPIRATORY TRACT INFECTION 6 0.0013
504 MEDICATION ERROR 70 0.0013
505 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 9 0.0013
506 HEART RATE ABNORMAL 7 0.0013
507 UPPER LIMB FRACTURE 25 0.0013
508 LABORATORY TEST ABNORMAL 37 0.0013
509 FATIGUE 972 0.0012
510 PRESYNCOPE 30 0.0012
511 FACIAL PAIN 11 0.0012
512 DRUG SPECIFIC ANTIBODY PRESENT 8 0.0012
513 RESPIRATORY TRACT INFECTION 32 0.0012
514 DIARRHOEA 789 0.0012
515 THROAT TIGHTNESS 33 0.0012
516 SENSITIVE SKIN 9 0.0012
517 KNEE OPERATION 12 0.0012
518 JOINT INJURY 26 0.0012
519 BLADDER DISORDER 12 0.0012
520 DEVICE OCCLUSION 17 0.0012
521 SKIN REACTION 17 0.0012
522 INJECTION SITE SWELLING 92 0.0012
523 NEPHROLITHIASIS 55 0.0012
524 BREAST MASS 8 0.0012
525 STAPHYLOCOCCAL INFECTION 39 0.0012
526 LIP OEDEMA 5 0.0012
527 MUSCLE FATIGUE 5 0.0012
528 PARAESTHESIA ORAL 17 0.0012
529 ACCIDENT 14 0.0012
530 WRIST FRACTURE 14 0.0012
531 PRODUCT TEMPERATURE EXCURSION ISSUE 6 0.0012
532 OEDEMA PERIPHERAL 142 0.0012
533 CERVICAL VERTEBRAL FRACTURE 4 0.0012
534 PRODUCT PACKAGING ISSUE 11 0.0012
535 MUSCLE STRAIN 10 0.0012
536 NAUSEA 909 0.0011
537 POST PROCEDURAL COMPLICATION 22 0.0011
538 RECTAL HAEMORRHAGE 49 0.0011
539 IMMUNODEFICIENCY 17 0.0011
540 EMBOLIC STROKE 4 0.0011
541 FEEDING DISORDER 23 0.0011
542 LIGAMENT RUPTURE 5 0.0011
543 APPENDICECTOMY 4 0.0011
544 INJECTION SITE DISCOLOURATION 14 0.0011
545 SWELLING OF EYELID 7 0.0011
546 BUNDLE BRANCH BLOCK RIGHT 5 0.0011
547 LOCALISED INFECTION 26 0.0011
548 ADRENAL INSUFFICIENCY 13 0.0011
549 PREMATURE LABOUR 6 0.0011
550 CHEMOTHERAPY 4 0.0011
551 PARANASAL SINUS DISCOMFORT 4 0.0011
552 SPINAL OPERATION 13 0.0011
553 FACE INJURY 4 0.0011
554 INTERNAL HAEMORRHAGE 12 0.0010
555 NEUROLOGICAL SYMPTOM 6 0.0010
556 GESTATIONAL DIABETES 5 0.0010
557 CLAVICLE FRACTURE 4 0.0010
558 INJECTION SITE ERYTHEMA 129 0.0010
559 HERNIA 20 0.0010
560 INCORRECT DOSAGE ADMINISTERED 5 0.0010
561 STAPHYLOCOCCAL SEPSIS 5 0.0010
562 INJECTION SITE RASH 31 0.0010
563 PULMONARY THROMBOSIS 11 0.0010
564 HEPATIC ENZYME ABNORMAL 5 0.0010
565 TRANSPLANT REJECTION 8 0.0010
566 INJECTION SITE PAIN 306 0.0010
567 HAND FRACTURE 7 0.0010
568 FOETAL GROWTH RESTRICTION 6 0.0010
569 POST PROCEDURAL INFECTION 8 0.0010
570 INTESTINAL OBSTRUCTION 37 0.0010
571 SKIN INFECTION 11 0.0010
572 NERVE COMPRESSION 9 0.0010
573 EYE INFECTION 11 0.0010
574 INJECTION SITE PRURITUS 65 0.0010
575 ANKLE FRACTURE 15 0.0010
576 OVERDOSE 209 0.0010
577 CYST 12 0.0010
578 MENSTRUAL DISORDER 8 0.0010
579 BACTERIAL INFECTION 18 0.0010
580 ANXIETY 274 0.0010
581 INTENTIONAL UNDERDOSE 7 0.0010
582 INTENTIONAL DOSE OMISSION 27 0.0009
583 EYELID OEDEMA 11 0.0009
584 DRUG EFFECT LESS THAN EXPECTED 14 0.0009
585 TOOTHACHE 17 0.0009
586 MASS 13 0.0009
587 HORDEOLUM 4 0.0009
588 FLUID RETENTION 47 0.0009
589 VISUAL IMPAIRMENT 113 0.0009
590 CYSTITIS 29 0.0009
591 GASTROINTESTINAL PAIN 10 0.0009
592 GINGIVAL SWELLING 4 0.0009
593 ABDOMINAL ABSCESS 4 0.0009
594 EXPIRED PRODUCT ADMINISTERED 30 0.0009
595 INTENTIONAL PRODUCT MISUSE 79 0.0009
596 PYREXIA 311 0.0009
597 INTRACRANIAL PRESSURE INCREASED 5 0.0009
598 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 30 0.0009
599 EYE SWELLING 33 0.0009
600 PERIORBITAL SWELLING 5 0.0009
601 IMPAIRED GASTRIC EMPTYING 12 0.0009
602 SEPSIS 98 0.0009
603 SCAR 15 0.0009
604 GASTRITIS 23 0.0009
605 SURGERY 51 0.0009
606 RHINITIS 7 0.0009
607 LYMPHOEDEMA 6 0.0009
608 SKIN WARM 5 0.0009
609 SYRINGE ISSUE 15 0.0009
610 COLD SWEAT 15 0.0009
611 LOSS OF CONSCIOUSNESS 109 0.0008
612 IMPAIRED WORK ABILITY 18 0.0008
613 THERAPEUTIC RESPONSE DECREASED 51 0.0008
614 BEDRIDDEN 11 0.0008
615 BLOOD POTASSIUM DECREASED 25 0.0008
616 NEURALGIA 20 0.0008
617 GAIT DISTURBANCE 157 0.0008
618 ORAL DISORDER 6 0.0008
619 MOUTH HAEMORRHAGE 6 0.0008
620 HEPATOMEGALY 8 0.0008
621 CEREBRAL DISORDER 6 0.0008
622 SYNCOPE 81 0.0008
623 NERVE INJURY 9 0.0008
624 BLOOD PRESSURE ABNORMAL 16 0.0008
625 ILEUS 10 0.0008
626 OVARIAN CYST 8 0.0008
627 EPSTEIN-BARR VIRUS INFECTION 5 0.0008
628 GALLBLADDER DISORDER 14 0.0008
629 PHLEBITIS 4 0.0008
630 ENDOCARDITIS 4 0.0008
631 FACE OEDEMA 13 0.0008
632 POLYP 5 0.0008
633 POOR QUALITY PRODUCT ADMINISTERED 8 0.0008
634 BACTERAEMIA 9 0.0008
635 MENTAL DISORDER 33 0.0008
636 SARS-COV-2 TEST POSITIVE 10 0.0008
637 BURNING SENSATION 53 0.0008
638 RENAL PAIN 8 0.0008
639 ARTHRITIS 59 0.0007
640 DEVICE DEFECTIVE 13 0.0007
641 OROPHARYNGEAL PAIN 69 0.0007
642 DRUG EFFECT INCOMPLETE 27 0.0007
643 POOR QUALITY SLEEP 16 0.0007
644 LEUKAEMIA 7 0.0007
645 COLITIS ISCHAEMIC 5 0.0007
646 PRODUCT PRESCRIBING ISSUE 16 0.0007
647 INTERVERTEBRAL DISC PROTRUSION 16 0.0007
648 GENERALISED OEDEMA 9 0.0007
649 INJECTION SITE NODULE 8 0.0007
650 HEART RATE INCREASED 72 0.0007
651 AUTISM SPECTRUM DISORDER 4 0.0007
652 TOOTH FRACTURE 8 0.0007
653 DROOLING 5 0.0007
654 DENTAL CARIES 8 0.0007
655 DIVERTICULITIS 20 0.0007
656 HEMIPLEGIA 6 0.0007
657 ORAL HERPES 14 0.0007
658 INFLAMMATORY BOWEL DISEASE 7 0.0007
659 ANGIOPATHY 4 0.0007
660 COUGH 198 0.0007
661 CHOLECYSTITIS ACUTE 4 0.0007
662 DEHYDRATION 94 0.0007
663 PSEUDOMONAS INFECTION 6 0.0007
664 ANAPHYLACTIC SHOCK 18 0.0007
665 INJECTION SITE INDURATION 9 0.0007
666 RESPIRATORY SYNCYTIAL VIRUS INFECTION 6 0.0007
667 GASTROENTERITIS 10 0.0007
668 PROCEDURAL PAIN 19 0.0007
669 HYPOVOLAEMIA 4 0.0007
670 EAR DISCOMFORT 7 0.0007
671 TEMPERATURE INTOLERANCE 7 0.0007
672 INJECTION SITE MASS 25 0.0007
673 BLOOD IRON DECREASED 8 0.0007
674 CARDIAC PACEMAKER INSERTION 4 0.0007
675 HYPERLIPIDAEMIA 8 0.0007
676 EMOTIONAL DISTRESS 81 0.0007
677 SNEEZING 15 0.0007
678 HEAVY MENSTRUAL BLEEDING 6 0.0007
679 SINUS CONGESTION 9 0.0007
680 DEPRESSED MOOD 35 0.0007
681 TRANSIENT ISCHAEMIC ATTACK 22 0.0007
682 URINARY TRACT INFECTION 111 0.0007
683 LYMPHOMA 10 0.0006
684 DEEP VEIN THROMBOSIS 42 0.0006
685 PELVIC FRACTURE 5 0.0006
686 GASTROINTESTINAL INFLAMMATION 5 0.0006
687 CYANOSIS 10 0.0006
688 PRODUCT PREPARATION ERROR 13 0.0006
689 PANIC ATTACK 23 0.0006
690 FURUNCLE 5 0.0006
691 CARDIOGENIC SHOCK 9 0.0006
692 HERPES ZOSTER 36 0.0006
693 MALNUTRITION 7 0.0006
694 HAEMOGLOBIN ABNORMAL 4 0.0006
695 LIMB DISCOMFORT 19 0.0006
696 PULMONARY EMBOLISM 58 0.0006
697 ESCHERICHIA INFECTION 5 0.0006
698 OSTEOMYELITIS 11 0.0006
699 COLITIS ULCERATIVE 27 0.0006
700 DYSMENORRHOEA 8 0.0006
701 APPETITE DISORDER 4 0.0006
702 THROAT IRRITATION 27 0.0006
703 CYTOMEGALOVIRUS INFECTION 10 0.0006
704 EYE HAEMORRHAGE 8 0.0006
705 MENINGITIS 4 0.0006
706 APHASIA 18 0.0006
707 PRODUCT PHYSICAL ISSUE 12 0.0006
708 HYPERSOMNIA 17 0.0006
709 RASH PRURITIC 32 0.0006
710 ABNORMAL LOSS OF WEIGHT 4 0.0006
711 CARDIAC OPERATION 5 0.0006
712 SEIZURE 67 0.0006
713 NASAL CONGESTION 34 0.0006
714 PRURITUS 221 0.0006
715 TACHYCARDIA 51 0.0006
716 SCRATCH 6 0.0006
717 PNEUMOTHORAX 9 0.0006
718 PANIC REACTION 4 0.0006
719 ROTATOR CUFF SYNDROME 7 0.0005
720 BLOOD PRESSURE DECREASED 36 0.0005
721 HIATUS HERNIA 7 0.0005
722 INTERVERTEBRAL DISC DEGENERATION 5 0.0005
723 FUNGAL INFECTION 18 0.0005
724 PERSONALITY CHANGE 5 0.0005
725 FLANK PAIN 5 0.0005
726 INCORRECT DRUG ADMINISTRATION DURATION 15 0.0005
727 LACERATION 5 0.0005
728 ORAL CANDIDIASIS 7 0.0005
729 SPINAL DISORDER 5 0.0005
730 CATARACT 31 0.0005
731 ACUTE RESPIRATORY FAILURE 10 0.0005
732 ACCIDENTAL OVERDOSE 19 0.0005
733 HYPOTENSION 104 0.0005
734 APHTHOUS ULCER 4 0.0005
735 DRUG DOSE OMISSION 85 0.0005
736 SPINAL PAIN 6 0.0005
737 SKIN CANCER 11 0.0005
738 INFLUENZA LIKE ILLNESS 42 0.0005
739 NEOPLASM MALIGNANT 34 0.0005
740 CARDIAC DISORDER 47 0.0005
741 BODY TEMPERATURE INCREASED 10 0.0005
742 ASPHYXIA 4 0.0005
743 CHOLELITHIASIS 16 0.0005
744 HAEMORRHAGE 51 0.0005
745 ACCIDENTAL UNDERDOSE 7 0.0005
746 INJECTION SITE EXTRAVASATION 6 0.0005
747 FEAR 13 0.0005
748 PALPITATIONS 56 0.0005
749 PALLOR 13 0.0005
750 BODY HEIGHT DECREASED 5 0.0005
751 GASTRIC DISORDER 16 0.0005
752 MUSCULOSKELETAL DISCOMFORT 8 0.0005
753 HYPOAESTHESIA ORAL 7 0.0005
754 PRURITUS GENERALISED 10 0.0005
755 PRODUCT PRESCRIBING ERROR 11 0.0005
756 OESOPHAGITIS 5 0.0005
757 GROIN PAIN 4 0.0005
758 THYROID DISORDER 7 0.0005
759 MUSCULOSKELETAL CHEST PAIN 7 0.0005
760 CHILLS 53 0.0005
761 TENDONITIS 7 0.0005
762 HEAD DISCOMFORT 8 0.0005
763 LUNG INFECTION 7 0.0005
764 URINARY RETENTION 15 0.0004
765 RHINORRHOEA 29 0.0004
766 COLITIS 17 0.0004
767 EXTRA DOSE ADMINISTERED 18 0.0004
768 GASTROINTESTINAL CARCINOMA 4 0.0004
769 CRYING 16 0.0004
770 SCAB 5 0.0004
771 CHOLECYSTECTOMY 5 0.0004
772 RIB FRACTURE 9 0.0004
773 PNEUMONIA BACTERIAL 4 0.0004
774 NEOPLASM 5 0.0004
775 RESPIRATORY DISTRESS 12 0.0004
776 FEELING ABNORMAL 104 0.0004
777 BLOOD PRESSURE INCREASED 66 0.0004
778 FEELING COLD 12 0.0004
779 POST PROCEDURAL HAEMORRHAGE 5 0.0004
780 RENAL DISORDER 20 0.0004
781 SPLENOMEGALY 5 0.0004
782 PAIN IN JAW 12 0.0004
783 DYSPHAGIA 40 0.0004
784 COAGULOPATHY 7 0.0004
785 PARALYSIS 6 0.0004
786 AFFECT LABILITY 4 0.0004
787 GLAUCOMA 8 0.0004
788 FAECES DISCOLOURED 9 0.0004
789 ATELECTASIS 4 0.0004
790 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
791 HYPOKALAEMIA 19 0.0004
792 NO THERAPEUTIC RESPONSE 5 0.0004
793 ERYTHEMA 84 0.0004
794 RASH PAPULAR 9 0.0004
795 BRAIN INJURY 4 0.0004
796 HEART RATE DECREASED 14 0.0004
797 PSORIASIS 52 0.0004
798 LACRIMATION INCREASED 12 0.0004
799 CELLULITIS 20 0.0004
800 PRODUCT ADMINISTRATION ERROR 8 0.0004
801 VERTIGO 24 0.0004
802 OXYGEN SATURATION DECREASED 22 0.0004
803 INJECTION SITE WARMTH 8 0.0004
804 RASH GENERALISED 10 0.0004
805 IMMUNE SYSTEM DISORDER 5 0.0004
806 INCONTINENCE 4 0.0004
807 EATING DISORDER 8 0.0004
808 THINKING ABNORMAL 7 0.0004
809 QUALITY OF LIFE DECREASED 5 0.0004
810 DYSARTHRIA 14 0.0004
811 MENTAL IMPAIRMENT 9 0.0004
812 DECREASED ACTIVITY 4 0.0004
813 MUSCLE TIGHTNESS 6 0.0004
814 BACK PAIN 86 0.0004
815 MUSCULOSKELETAL DISORDER 7 0.0004
816 PRODUCT DISPENSING ERROR 8 0.0004
817 FEELING JITTERY 7 0.0004
818 MOOD ALTERED 10 0.0004
819 NERVOUSNESS 19 0.0004
820 GENERALISED TONIC-CLONIC SEIZURE 6 0.0004
821 THERAPEUTIC RESPONSE SHORTENED 12 0.0004
822 CHOKING 7 0.0004
823 FISTULA 4 0.0004
824 DRUG EFFECT DECREASED 19 0.0004
825 NERVOUS SYSTEM DISORDER 11 0.0004
826 IMPAIRED QUALITY OF LIFE 5 0.0003
827 HAEMATOMA 9 0.0003
828 MOVEMENT DISORDER 11 0.0003
829 GOUT 6 0.0003
830 DEVICE FAILURE 5 0.0003
831 RETCHING 7 0.0003
832 RESPIRATORY ARREST 9 0.0003
833 HYPERHIDROSIS 42 0.0003
834 DYSURIA 12 0.0003
835 SPEECH DISORDER 17 0.0003
836 INCORRECT DOSE ADMINISTERED 74 0.0003
837 ABNORMAL WEIGHT GAIN 4 0.0003
838 DEVICE LEAKAGE 14 0.0003
839 DEMENTIA 9 0.0003
840 BASAL CELL CARCINOMA 5 0.0003
841 PRODUCT STORAGE ERROR 28 0.0003
842 ABDOMINAL PAIN LOWER 8 0.0003
843 RESPIRATORY TRACT CONGESTION 5 0.0003
844 ABSCESS 5 0.0003
845 DEVICE MALFUNCTION 22 0.0003
846 CEREBROVASCULAR ACCIDENT 53 0.0003
847 BLOOD POTASSIUM INCREASED 5 0.0003
848 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 16 0.0003
849 MENORRHAGIA 6 0.0003
850 SKIN DISCOLOURATION 14 0.0003
851 MULTIPLE FRACTURES 5 0.0003
852 DISORIENTATION 12 0.0003
853 VENTRICULAR TACHYCARDIA 5 0.0003
854 DEATH 260 0.0003
855 TREMOR 50 0.0003
856 LEUKOPENIA 15 0.0003
857 SPINAL FRACTURE 6 0.0003
858 EYE PRURITUS 10 0.0003
859 CANDIDA INFECTION 5 0.0003
860 INJURY ASSOCIATED WITH DEVICE 6 0.0003
861 BLINDNESS 12 0.0003
862 DRUG ADMINISTRATION ERROR 9 0.0003
863 EMOTIONAL DISORDER 9 0.0003
864 INJECTION SITE HAEMORRHAGE 23 0.0003
865 RASH MACULAR 10 0.0003
866 CARPAL TUNNEL SYNDROME 4 0.0003
867 MYALGIA 48 0.0003
868 EPISTAXIS 21 0.0003
869 HYPOPHAGIA 7 0.0003
870 EYE DISORDER 9 0.0003
871 COMA 13 0.0003
872 HAEMATOCHEZIA 15 0.0003
873 PHOTOPHOBIA 5 0.0003
874 HEART RATE IRREGULAR 6 0.0003
875 DYSPNOEA EXERTIONAL 10 0.0003
876 BLOOD SODIUM DECREASED 5 0.0003
877 FLATULENCE 15 0.0003
878 BRADYCARDIA 14 0.0003
879 BLOOD URINE PRESENT 5 0.0003
880 GASTRIC ULCER 5 0.0003
881 AGGRESSION 13 0.0003
882 PERICARDIAL EFFUSION 6 0.0003
883 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 52 0.0003
884 HAEMORRHOIDS 5 0.0003
885 LYMPHADENOPATHY 9 0.0003
886 SEPTIC SHOCK 11 0.0003
887 MOOD SWINGS 8 0.0003
888 BLOOD PRESSURE FLUCTUATION 6 0.0002
889 RESTLESSNESS 9 0.0002
890 SOMNOLENCE 49 0.0002
891 PHOTOSENSITIVITY REACTION 4 0.0002
892 TOOTH LOSS 5 0.0002
893 VISION BLURRED 33 0.0002
894 TINNITUS 11 0.0002
895 HAEMATEMESIS 6 0.0002
896 ATRIAL FIBRILLATION 23 0.0002
897 HEMIPARESIS 4 0.0002
898 FLUSHING 24 0.0002
899 CONSTIPATION 51 0.0002
900 UNRESPONSIVE TO STIMULI 6 0.0002
901 EYE PAIN 13 0.0002
902 VAGINAL HAEMORRHAGE 10 0.0002
903 CONVULSION 13 0.0002
904 LETHARGY 13 0.0002
905 ISCHAEMIC STROKE 4 0.0002
906 BONE PAIN 13 0.0002
907 NEUROPATHY PERIPHERAL 21 0.0002
908 SKIN IRRITATION 10 0.0002
909 AGITATION 16 0.0002
910 HIP FRACTURE 7 0.0002
911 CONJUNCTIVITIS 4 0.0002
912 HAEMOPTYSIS 6 0.0002
913 BREAST CANCER 20 0.0002
914 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
915 RASH ERYTHEMATOUS 10 0.0002
916 MYOCARDIAL INFARCTION 36 0.0002
917 LIVER FUNCTION TEST ABNORMAL 6 0.0002
918 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
919 DISTURBANCE IN ATTENTION 11 0.0002
920 GASTROINTESTINAL HAEMORRHAGE 17 0.0002
921 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
922 PNEUMONIA ASPIRATION 5 0.0002
923 HOT FLUSH 15 0.0002
924 HYPOXIA 7 0.0002
925 DEVICE BREAKAGE 8 0.0002
926 CARDIOVASCULAR DISORDER 5 0.0002
927 INCORRECT ROUTE OF DRUG ADMINISTRATION 7 0.0002
928 WRONG TECHNIQUE IN DRUG USAGE PROCESS 7 0.0002
929 RESPIRATORY FAILURE 14 0.0002
930 POLLAKIURIA 8 0.0002
931 MOUTH ULCERATION 4 0.0002
932 PRODUCTIVE COUGH 9 0.0002
933 HYPOACUSIS 8 0.0002
934 JAUNDICE 5 0.0002
935 DEVICE DISLOCATION 8 0.0002
936 APPLICATION SITE PAIN 4 0.0002
937 SKIN DISORDER 6 0.0002
938 PLASMA CELL MYELOMA 7 0.0002
939 ORAL PAIN 4 0.0002
940 CHROMATURIA 4 0.0002
941 ANGINA PECTORIS 5 0.0002
942 BALANCE DISORDER 15 0.0002
943 DIABETES MELLITUS 13 0.0002
944 ASCITES 5 0.0002
945 CARDIAC ARREST 14 0.0002
946 ASPARTATE AMINOTRANSFERASE INCREASED 9 0.0002
947 IRRITABILITY 10 0.0002
948 HEPATIC FAILURE 5 0.0002
949 PLEURAL EFFUSION 10 0.0002
950 ANAEMIA 30 0.0002
951 WHITE BLOOD CELL COUNT DECREASED 17 0.0002
952 PULMONARY OEDEMA 7 0.0002
953 DEAFNESS 4 0.0002
954 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
955 OCULAR HYPERAEMIA 7 0.0001
956 DRUG EXPOSURE DURING PREGNANCY 5 0.0001
957 HAEMOGLOBIN DECREASED 15 0.0001
958 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
959 DYSSTASIA 4 0.0001
960 CARDIAC FAILURE CONGESTIVE 11 0.0001
961 DYSGEUSIA 10 0.0001
962 ACNE 10 0.0001
963 RENAL FAILURE 17 0.0001
964 SKIN BURNING SENSATION 9 0.0001
965 OSTEONECROSIS 4 0.0001
966 RENAL IMPAIRMENT 10 0.0001
967 THROMBOCYTOPENIA 13 0.0001
968 NEOPLASM PROGRESSION 4 0.0001
969 ECZEMA 6 0.0001
970 BLOOD CREATININE INCREASED 7 0.0001
971 DRUG INTERACTION 17 0.0001
972 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 5 0.0001
973 ARRHYTHMIA 5 0.0001
974 BLOOD GLUCOSE DECREASED 5 0.0001
975 ABNORMAL BEHAVIOUR 4 0.0001
976 DYSKINESIA 4 0.0001
977 SUICIDAL IDEATION 9 0.0001
978 INTENTIONAL OVERDOSE 6 0.0001
979 PROSTATE CANCER 7 0.0001
980 HYPOGLYCAEMIA 4 0.0001
981 ALANINE AMINOTRANSFERASE INCREASED 5 0.0001
982 DEVICE DIFFICULT TO USE 5 0.0001
983 CARDIAC FAILURE 6 0.0001
984 BLOOD GLUCOSE INCREASED 14 0.0001
985 CHRONIC KIDNEY DISEASE 5 0.0001
986 COMPLETED SUICIDE 5 0.0001
987 DRY SKIN 7 0.0001
988 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
989 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
990 PLATELET COUNT DECREASED 5 0.0000
991 DRUG DEPENDENCE 7 0.0000
992 ACUTE KIDNEY INJURY 6 0.0000
993 NEUTROPENIA 5 0.0000